Status:
COMPLETED
EHR-integrated rUTI Texting Platform
Lead Sponsor:
University of Pennsylvania
Collaborating Sponsors:
Independence Blue Cross
Conditions:
Recurrent Urinary Tract Infection
Eligibility:
FEMALE
18-100 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to compare a texting platform to usual care for managing recurrent urinary tract infections (UTI). The main question it aims to answer is: • can a texting platform...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Females who currently meet the criteria for recurrent UTIs
- Age 18 years or older
- Owns a mobile device with text messaging capability
- Ability to read and write English
- Currently receiving care from a provider in Penn Urogynecology or Penn Urology
- Exclusion criteria:
- History of known multidrug resistant UTIs
- History of interstitial cystitis/bladder pain syndrome or current diagnosis of chronic pelvic pain
- On continuous suppressive antibiotics currently
- Currently pregnant or within 6 weeks of pregnancy
- Transplant patient on immunosuppressive medication currently
- Practice of chronic self-catheterization
Exclusion
Key Trial Info
Start Date :
March 7 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2025
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT06035601
Start Date
March 7 2024
End Date
May 31 2025
Last Update
August 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104